155 related articles for article (PubMed ID: 37021926)
1. Prevalence of pathogenic variants in cancer-predisposing genes in second cancer after childhood solid cancers.
Yoshida M; Nakabayashi K; Yang W; Sato-Otsubo A; Tsujimoto SI; Ogata-Kawata H; Kawai T; Ishiwata K; Sakamoto M; Okamura K; Yoshida K; Shirai R; Osumi T; Kiyotani C; Shioda Y; Terashima K; Ishimaru S; Yuza Y; Takagi M; Arakawa Y; Imamura T; Hasegawa D; Inoue A; Yoshioka T; Ito S; Tomizawa D; Koh K; Matsumoto K; Kiyokawa N; Ogawa S; Manabe A; Niwa A; Hata K; Yang JJ; Kato M
Cancer Med; 2023 May; 12(10):11264-11273. PubMed ID: 37021926
[TBL] [Abstract][Full Text] [Related]
2. Somatic and Germline
Sherborne AL; Lavergne V; Yu K; Lee L; Davidson PR; Mazor T; Smirnoff IV; Horvai AE; Loh M; DuBois SG; Goldsby RE; Neglia JP; Hammond S; Robison LL; Wustrack R; Costello JF; Nakamura AO; Shannon KM; Bhatia S; Nakamura JL
Clin Cancer Res; 2017 Apr; 23(7):1852-1861. PubMed ID: 27683180
[No Abstract] [Full Text] [Related]
3. NUDT15 variants confer high incidence of second malignancies in children with acute lymphoblastic leukemia.
Yoshida M; Nakabayashi K; Yang W; Sato-Otsubo A; Tsujimoto SI; Ogata-Kawata H; Kawai T; Ishiwata K; Sakamoto M; Okamura K; Yoshida K; Shirai R; Osumi T; Moriyama T; Nishii R; Takahashi H; Kiyotani C; Shioda Y; Terashima K; Ishimaru S; Yuza Y; Takagi M; Arakawa Y; Kinoshita A; Hino M; Imamura T; Hasegawa D; Nakazawa Y; Okuya M; Kakuda H; Takasugi N; Inoue A; Ohki K; Yoshioka T; Ito S; Tomizawa D; Koh K; Matsumoto K; Sanada M; Kiyokawa N; Ohara A; Ogawa S; Manabe A; Niwa A; Hata K; Yang JJ; Kato M
Blood Adv; 2021 Dec; 5(23):5420-5428. PubMed ID: 34662904
[TBL] [Abstract][Full Text] [Related]
4. [Genetic basis of subsequent malignant neoplasms].
Yoshida M; Kato M
Rinsho Ketsueki; 2020; 61(9):1174-1178. PubMed ID: 33162513
[TBL] [Abstract][Full Text] [Related]
5. Germline MUTYH Mutation in a Pediatric Cancer Survivor Developing a Secondary Malignancy.
Lavergne V; Sabnis A; Tupule A; Davidson PR; Kline C; Matthay K; Nicolaides T; Goldsby R; Braunstein S; Fogh SE; Sneed PK; Menzel P; Nakamura A; DuBois SG; Haas-Kogan DA; Nakamura JL
J Pediatr Hematol Oncol; 2020 Oct; 42(7):e647-e654. PubMed ID: 31815884
[TBL] [Abstract][Full Text] [Related]
6. A Genome-First Approach to Characterize DICER1 Pathogenic Variant Prevalence, Penetrance, and Phenotype.
Mirshahi UL; Kim J; Best AF; Chen ZE; Hu Y; Haley JS; Golden A; Stahl R; Manickam K; Carr AG; Harney LA; Field A; Hatton J; Schultz KAP; Bauer AJ; Hill DA; Rosenberg PS; Murray MF; Carey DJ; Stewart DR
JAMA Netw Open; 2021 Feb; 4(2):e210112. PubMed ID: 33630087
[TBL] [Abstract][Full Text] [Related]
7. Lack of pathogenic germline DICER1 variants in males with testicular germ-cell tumors.
Vasta LM; McMaster ML; Harney LA; Ling A; Kim J; Harris AK; Carr AG; Damrauer SM; Rader DJ; Kember RL; Kanetsky PA; Nathanson KL; Pyle LC; Greene MH; Schultz KA; Stewart DR;
Cancer Genet; 2020 Oct; 248-249():49-56. PubMed ID: 33158809
[TBL] [Abstract][Full Text] [Related]
8. Predominant
Lee YA; Im SW; Jung KC; Chung EJ; Shin CH; Kim JI; Park YJ
Thyroid; 2020 Aug; 30(8):1120-1131. PubMed ID: 32228164
[No Abstract] [Full Text] [Related]
9. Second malignant neoplasms in patients with Cowden syndrome with underlying germline PTEN mutations.
Ngeow J; Stanuch K; Mester JL; Barnholtz-Sloan JS; Eng C
J Clin Oncol; 2014 Jun; 32(17):1818-24. PubMed ID: 24778394
[TBL] [Abstract][Full Text] [Related]
10. Rare Germline
Martínez de LaPiscina I; Hernández-Ramírez LC; Portillo N; Gómez-Gila AL; Urrutia I; Martínez-Salazar R; García-Castaño A; Aguayo A; Rica I; Gaztambide S; Faucz FR; Keil MF; Lodish MB; Quezado M; Pankratz N; Chittiboina P; Lane J; Kay DM; Mills JL; Castaño L; Stratakis CA
Front Endocrinol (Lausanne); 2020; 11():433. PubMed ID: 32714280
[No Abstract] [Full Text] [Related]
11. The prevalence of DICER1 pathogenic variation in population databases.
Kim J; Field A; Schultz KAP; Hill DA; Stewart DR
Int J Cancer; 2017 Nov; 141(10):2030-2036. PubMed ID: 28748527
[TBL] [Abstract][Full Text] [Related]
12. Germline Mutations for Novel Candidate Predisposition Genes in Sporadic Schwannomatosis.
Min BJ; Kang YK; Chung YG; Seo ME; Chang KB; Joo MW
Clin Orthop Relat Res; 2020 Nov; 478(11):2442-2450. PubMed ID: 32281771
[TBL] [Abstract][Full Text] [Related]
13. Risk of Solid Cancer After Treatment of Testicular Germ Cell Cancer in the Platinum Era.
Groot HJ; Lubberts S; de Wit R; Witjes JA; Kerst JM; de Jong IJ; Groenewegen G; van den Eertwegh AJM; Poortmans PM; Klümpen HJ; van den Berg HA; Smilde TJ; Vanneste BGL; Aarts MJ; Incrocci L; van den Bergh ACM; Jóźwiak K; van den Belt-Dusebout AW; Horenblas S; Gietema JA; van Leeuwen FE; Schaapveld M
J Clin Oncol; 2018 Aug; 36(24):2504-2513. PubMed ID: 29989856
[TBL] [Abstract][Full Text] [Related]
14. Clinical trio genome sequencing facilitates the interpretation of variants in cancer predisposition genes in paediatric tumour patients.
Schroeder C; Faust U; Krauße L; Liebmann A; Abele M; Demidov G; Schütz L; Kelemen O; Pohle A; Gauß S; Sturm M; Roggia C; Streiter M; Buchert R; Armenau-Ebinger S; Nann D; Beschorner R; Handgretinger R; Ebinger M; Lang P; Holzer U; Skokowa J; Ossowski S; Haack TB; Mau-Holzmann UA; Dufke A; Riess O; Brecht IB
Eur J Hum Genet; 2023 Oct; 31(10):1139-1146. PubMed ID: 37507557
[TBL] [Abstract][Full Text] [Related]
15. Prevalence of Pathogenic Germline
Altaraihi M; Hansen TVO; Santoni-Rugiu E; Rossing M; Rasmussen ÅK; Gerdes AM; Wadt K
Front Endocrinol (Lausanne); 2021; 12():727970. PubMed ID: 34552563
[TBL] [Abstract][Full Text] [Related]
16. Germline and somatic DICER1 mutations in familial and sporadic liver tumors.
Caruso S; Calderaro J; Letouzé E; Nault JC; Couchy G; Boulai A; Luciani A; Zafrani ES; Bioulac-Sage P; Seror O; Imbeaud S; Zucman-Rossi J
J Hepatol; 2017 Apr; 66(4):734-742. PubMed ID: 28012864
[TBL] [Abstract][Full Text] [Related]
17. Germline genetic variants in men with prostate cancer and one or more additional cancers.
Pilié PG; Johnson AM; Hanson KL; Dayno ME; Kapron AL; Stoffel EM; Cooney KA
Cancer; 2017 Oct; 123(20):3925-3932. PubMed ID: 28657667
[TBL] [Abstract][Full Text] [Related]
18. Clinical heterogeneity and reduced penetrance in DICER1 syndrome: a report of three families.
Azzollini J; Ferrari A; Stracuzzi A; Chiaravalli S; Terenziani M; Spreafico F; Grasso M; Collini P; Pensotti V; Massimino M; Arbustini E; Manoukian S
Tumori; 2021 Dec; 107(6):NP144-NP148. PubMed ID: 34761719
[TBL] [Abstract][Full Text] [Related]
19. Childhood Rhabdomyosarcoma of the Female Genital Tract: Association with Pathogenic DICER1 Variation, Clinicopathological Features, and Outcomes.
Kebudi R; Dural O; Bay SB; Gorgun O; Onder S; Bilgic B; Yilmaz I; Iribas A; Arndt CA; Harris AK; Field A; Schultz KAP; Hill DA
J Pediatr Adolesc Gynecol; 2021 Aug; 34(4):449-453. PubMed ID: 33484847
[TBL] [Abstract][Full Text] [Related]
20. Rare germline variants in childhood cancer patients suspected of genetic predisposition to cancer.
Sylvester DE; Chen Y; Grima N; Saletta F; Padhye B; Bennetts B; Wright D; Krivanek M; Graf N; Zhou L; Catchpoole D; Kirk J; Latchoumanin O; Qiao L; Ballinger M; Thomas D; Jamieson R; Dalla-Pozza L; Byrne JA
Genes Chromosomes Cancer; 2022 Feb; 61(2):81-93. PubMed ID: 34687117
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
